Geode Capital Management, LLC Aditxt, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.13 - $0.46 $4,514 - $15,973	34,726 Added 18.95%	217,991 $31,000
Q1 2022 May 13, 2022	BUY	$0.34 - $0.58 $1,775 - $3,028	5,222 Added 2.93%	183,265 $83,000
Q4 2021 Feb 11, 2022	SELL	$0.54 - $2.51 $12,192 - $56,673	-22,579 Reduced 11.25%	178,043 $95,000
Q3 2021 Nov 12, 2021	BUY	$1.54 - $3.04 $167,254 - $330,165	108,607 Added 118.03%	200,622 $339,000
Q2 2021 Aug 13, 2021	BUY	$2.2 - $3.2 $22,503 - $32,732	10,229 Added 12.51%	92,015 $238,000
Q1 2021 May 12, 2021	BUY	$2.08 - $5.26 $170,114 - $430,194	81,786 New	81,786 $208,000

Ticker ADTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,161,130
Market Cap $749K
Description
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.